Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Blood Research|June 30, 2021
Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicityJunshik Hong, Yoo Jin Lee, Sung Hwa Bae, et al.
Annals of Hematology|January 4, 2020
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphomaYoung-Woong Won, Hyewon Lee, Hyeon-Seok Eom, et al.
Oncotarget|August 23, 2015
Patient-derived cell models as preclinical tools for genome-directed targeted therapyJi Yun Lee, Sun Young Kim, Charny Park, et al.
Cancer Research and Treatment|September 2, 2015
A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and HistologyJun Ho Yi, Jung Hun Kang, In Gyu Hwang, et al.
Cancers|February 13, 2026
Second Salvage Autologous Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Multiple Myeloma in the Era of Novel Agents: Results of the KMM2301 StudyJongheon Jung, Ji Hyun Lee, Sung-Hyun Kim, et al.
Blood Cancer Journal|December 2, 2021
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CTHee Jeong Cho, Sung-Hoon Jung, Jae-Cheol Jo, et al.
Cancer|January 4, 2026
Efficacy and safety of teclistamab in triple-class exposed relapsed/refractory multiple myeloma: Pooled findings from three clinical cohorts and a retrospective cohortThomas G Martin, María-Victoria Mateos, Jun Ho Yi, et al.
Cancer Research and Treatment|January 3, 2023
Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404)Hyungwoo Cho, Dok Hyun Yoon, Dong-Yeop Shin, et al.
International Journal of Hematology|September 5, 2020
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasoneHo Sup Lee, Kihyun Kim, Je-Jung Lee, et al.
Annals of Hematology|December 25, 2019
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study)Jae-Cheol Jo, Ho Sup Lee, Kihyun Kim, et al.
Pageof 7